Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
AWHONN Lifelines|March 20, 2002
Teaching with toys. Invigorating your style with creativityC L Wallerstedt, B V Fletcher
Science (New York, N.Y.)|February 25, 1972
Delta 9-tetrahydrocannabinol: aversive effects in rat at high dosesT F Elsmore, G V Fletcher
Respiratory Medicine|November 8, 2006
The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysisSophie V Fletcher, Robin J Clark
Current HIV/AIDS Reports|August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitorsPeter L Anderson, Courtney V Fletcher
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1988
Neurological complications of central venous cannulationR J Defalque, M V Fletcher
Pharmacotherapy|November 1, 1996
Variability in zidovudine serum concentrationsC V Fletcher, H H Balfour
The Annals of Pharmacotherapy|May 1, 1992
Introduction to the "HIV and AIDS" columnS D Goodwin, C V Fletcher
The Annals of Pharmacotherapy|February 1, 1997
ValacyclovirE P Acosta, C V Fletcher
Current Infectious Disease Reports|July 27, 2001
Clinical Pharmacologic Considerations for HIV-1 Protease InhibitorsPeter L. Anderson, Courtney V. Fletcher
International Journal of Antimicrobial Agents|April 1, 1995
Antiretroviral drug interactionsE P Acosta, C V Fletcher
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
AWHONN Lifelines|March 20, 2002
Teaching with toys. Invigorating your style with creativityC L Wallerstedt, B V Fletcher
Science (New York, N.Y.)|February 25, 1972
Delta 9-tetrahydrocannabinol: aversive effects in rat at high dosesT F Elsmore, G V Fletcher
Respiratory Medicine|November 8, 2006
The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysisSophie V Fletcher, Robin J Clark
Current HIV/AIDS Reports|August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitorsPeter L Anderson, Courtney V Fletcher
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1988
Neurological complications of central venous cannulationR J Defalque, M V Fletcher
Pharmacotherapy|November 1, 1996
Variability in zidovudine serum concentrationsC V Fletcher, H H Balfour
The Annals of Pharmacotherapy|May 1, 1992
Introduction to the "HIV and AIDS" columnS D Goodwin, C V Fletcher
The Annals of Pharmacotherapy|February 1, 1997
ValacyclovirE P Acosta, C V Fletcher
Current Infectious Disease Reports|July 27, 2001
Clinical Pharmacologic Considerations for HIV-1 Protease InhibitorsPeter L. Anderson, Courtney V. Fletcher
International Journal of Antimicrobial Agents|April 1, 1995
Antiretroviral drug interactionsE P Acosta, C V Fletcher
Pageof 33